Response of the coronary vasculature to myocardial hypertrophy
- PMID: 1689327
- DOI: 10.1016/0735-1097(90)90620-5
Response of the coronary vasculature to myocardial hypertrophy
Abstract
Cardiac hypertrophy is often characterized by abnormalities in myocardial perfusion, including decreased coronary reserve, increased minimal coronary vascular resistance, underperfusion of the subendomyocardium during conditions of high oxygen demand and increased risk of infarction in the presence of coronary occlusion. Two major anatomic variables may cause these perfusion deficits. First, the coronary resistance vessels may not grow in proportion to the magnitude of the cardiac enlargement. Second, the luminal diameter of resistance vessels may become reduced as a consequence of medial hypertrophy, hyperplasia or fibrosis. A luminal narrowing coupled with a lack or inadequate numeric proliferation of resistance vessels can markedly limit maximal myocardial perfusion. However, not all models of cardiac hypertrophy are characterized by perfusion abnormalities. A substantial growth of arterioles and capillaries has been documented in exercise- and thyroxine-induced left ventricular hypertrophy. Moreover, at least in some models, angiogenesis occurs when the duration of the ventricular hypertrophy is sufficient. The hypothesis that coronary angiogenesis is stimulated by increased blood flow or prolongation of diastole appears to have support from a number of experimental studies. However, the cascade of events underlying angiogenesis and the numerous variables that characterize the various models of hypertrophy are complex and require elucidation.
Similar articles
-
Growth of the coronary vasculature in hypertrophy: mechanisms and model dependence.Cell Mol Biol Res. 1994;40(2):129-36. Cell Mol Biol Res. 1994. PMID: 7531558 Review.
-
Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis.Circ Res. 1985 Oct;57(4):591-8. doi: 10.1161/01.res.57.4.591. Circ Res. 1985. PMID: 2412724
-
Capillary and pre-capillary coronary vascular growth during left ventricular hypertrophy.Can J Cardiol. 1986 Mar-Apr;2(2):114-9. Can J Cardiol. 1986. PMID: 2423211
-
Coronary reserve in experimental myocardial hypertrophy.Eur Heart J. 1995 Aug;16 Suppl I:22-5. doi: 10.1093/eurheartj/16.suppl_i.22. Eur Heart J. 1995. PMID: 8829953 Review.
-
The effects of pressure-induced cardiac hypertrophy on the functional capacity of the coronary circulation.Am J Hypertens. 1988 Apr;1(2):200-7. doi: 10.1093/ajh/1.2.200. Am J Hypertens. 1988. PMID: 2969742
Cited by
-
MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.Arch Physiol Biochem. 2010 May;116(2):63-72. doi: 10.3109/13813451003652997. Arch Physiol Biochem. 2010. PMID: 20230216 Free PMC article.
-
Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension.Int J Mol Sci. 2018 Nov 27;19(12):3763. doi: 10.3390/ijms19123763. Int J Mol Sci. 2018. PMID: 30486375 Free PMC article.
-
Submaximal, aerobic exercise training exacerbates the cardiomyopathy of postweanling Cu-depleted rats.Biol Trace Elem Res. 1993 Sep;38(3):251-72. doi: 10.1007/BF02785310. Biol Trace Elem Res. 1993. PMID: 7504943
-
Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling.J Nucl Cardiol. 2009 Jan-Feb;16(1):73-81. doi: 10.1007/s12350-008-9006-4. Epub 2009 Jan 20. J Nucl Cardiol. 2009. PMID: 19152131
-
Coronary flow reserve.Br Heart J. 1993 Apr;69(4):279-81. doi: 10.1136/hrt.69.4.279. Br Heart J. 1993. PMID: 8489855 Free PMC article. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources